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I didn’t really mind having the
maitre ‘d take my temperature
each morning at breakfast. I didn’t
really mind staying in a towering
hotel that had more staff than
guests. And I didn’t mind that so
many people went about town in
cotton masks over their mouths.
But, one night over dinner in an
empty restaurant, I was
nonplussed when my dining
companion, Laurie Garrett,
remarked that we were the only
two science reporters in the world
who were sent to Beijing to cover
SARS. This is the biggest science
story of the year, she said. Why
did everyone stay home?
Laurie Garrett won a Pulitzer
Prize for her New York paper,
Newsday, a few years back when
she followed an epidemiologist
into the African bush to track
down the source of Ebola. And
with that kind of cache, Laurie can
pretty well call her own shots. My
network sent me because it took
SARS very seriously. Another
correspondent was dispatched to
Hong Kong and a third took a trip
to Toronto at the height of the
epidemic.
The rest of the news
organizations, however, simply
trusted their Beijing bureaus to
handle the story. During my two
weeks in Beijing, I understood
some of the logic in that.
First and foremost, the story in
Beijing was at least as much
about the remarkable behavior of
the Chinese government as it was
about a disease. Here was a
totalitarian regime promising to be
open and forthcoming. Even
Chinese journalists asked pointed
questions at Western-style press
conferences. And for a while
there, it seemed the government
in power could lose its grip.
I came to Beijing steeped in the
understanding of attack rates,
epidemic curves and microbiology.
My non-scientific colleagues had
an understanding of the Chinese
political system and they often had
a grip on the language. Everybody
had to learn a lot during the height
of the epidemic. I had to learn
about China; they had to learn the
difference between a virus and a
bacterium.
Naturally, my colleagues from
Beijing news bureaus were deeply
skeptical of every pronouncement
from the Chinese government.
Were they faking the data? How
much were they still covering up?
Chinese whispers
Under wraps: The SARS outbreak earlier this year caused worldwide panic at the prospect of a new human infectious disease.
People wore masks around the world, but journalists in China found that information about the disease was also initially under wraps.
(Photograpgh: Science Photo Library.)
Richard Harris, one of just two western sciece journalists sent to
Beijing to cover the SARS crisis earlier this year, reports on the
challenging conditions he encountered. 
Time magazine even managed a
scoop that asserted that Shanghai
had been hit much worse than
health authorities had admitted.
That’s the kind of story only a
reporter with Chinese street
smarts could get. The reporter
seemingly snuck into a hospital
dressed in a white coat and talked
to doctors who mistakenly
assumed the reporter was some
sort of health official. Yet no other
journalist ever confirmed that
report, and the Chinese
government never budged in its
claim that Shanghai was basically
spared. That story hangs today as
a big question mark. Scoop or
miscue? Who’s to say?
When a World Health
Organization team went into the
provinces to look for SARS, a
reporter for the Times of London
followed along in secret. He
staked out the hospital the WHO
team was to visit and noticed that
all the special precautions
demonstrated for the WHO
delegation were not practiced for
other visitors to the hospital. You
don’t need to be a science
reporter to do that story - you just
need an overdeveloped sense of
suspicion, which likely you would
develop by working in China for a
few years.
Still, there was a place for
science reporters. At one news
conference, Laurie Garrett
challenged the Chinese health
officials to explain their
unbelievably low mortality rate.
She pointed out that they were
simply dividing the number of
cases by the number of dead.
That produced a low mortality rate
because it assumed every case
currently alive would survive.
After talking quietly with some
of the international
epidemiologists on the scene, I
finally decided that the Chinese
disease rate reports were
believable (which isn’t quite the
same thing as being truthful). They
fit nicely on an epidemic curve
and accounted correctly for a
significant reporting lag. They
were also consistent with the
sometimes-draconian measures
the government and citizens of
China were taking to stop the
epidemic.
I spent hours arguing with a 
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BBC reporter about whether the
incidence figures were credible or
a tissue of lies. Finally, when the
Beijing government announced
that it was sending children back
to school, the BBC reporter
grudgingly admitted that the
epidemic must really be coming
under control.
Meanwhile, back in New York,
Washington, Los Angeles and
Chicago, science reporters kept
their hand in the SARS story by
telephone conference with the
WHO in Geneva and the Centers
for Disease Control and
Prevention in Atlanta. They missed
seeing the scared look of the cab
driver peering over his mask and
the desperate signs in the empty
restaurants declaring ‘No SARS.’
But we all had a perspective on
SARS, and it added up to one
dramatic story.
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Twelve key scientific nations,
including the US and the UK, and
others in Europe and elsewhere
have joined the International Stem
Cell Forum, which will standardize
research tools, benchmarks and
procedures. This will allow teams
in different countries to compare
results on the characteristics of
the cells and their possible use in
tackling conditions ranging from
diabetes to Parkinson’s.
UK scientists are set to take a
leading role. The project was
established at a meeting chaired
by the Mecical Research Council
lat month. It will be coordinated by
Peter Andrews, head of Sheffield
University’s Centre for Stem Cell
Biology
The MRC has already begun
work on a stem-cell bank for the
various lines of stem cells – each
derived from separate sources
around the world – that will
provide raw material for scientists.
The UK government has pledged
funds for stem-cell research, while
the European Commission
announced this week that it would
provide further resources subject
to strict ethical guidelines.
The work promises a
revolutionary way to repair
diseased and damaged body
tissues. Many scientists believe
that stem cells derived from
embryos have the most potential,
but ethical objections to such
experimentation have been raised.
Sir George Radda, the chief
executive of the MRC, who has
championed stem-cell research in
the UK, said he was pleased with
the speed with which the
mechanisms for global
cooperation – particularly in quality
control, intellectual property rights
and ethics – had been put in place.
`There is a will on everybody’s
part to do this in a coordinated
way. International coordination will
accelerate progress in research,
maximizing health benefits for the
global public,’ he said.
Data gathered by scientists in
the 12 countries will be posted in a
registry of stem-cell lines funded
by the forum. This will allow results
to be compared and stimulate
collaborations.
Two other key activities agreed
by the forum were international
practice on ethical and patenting
issues. These will be collated by
Canada and Australia, which will
report to the forum at its next
meeting in Sweden, in January.
Professor Radda said: `We hope
to map out an ethical landscape.
At the moment, a German
researcher funded by German
funds would be acting illegally if he
took part in research in the UK.’
After the meeting, the European
Commission published proposals
foe ethical guidelines for its
funding of stem-cell research as
part of the Sixth Framework
Programme.
New stem cell links
Researchers across 12 countries are joining forces to coordinate work
on stem cells that aims to streamline experimental approaches.
Nigel Williams reports. 
